{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T07:25:28Z","timestamp":1790925928735,"version":"4.1.0"},"reference-count":61,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,7,24]],"date-time":"2023-07-24T00:00:00Z","timestamp":1690156800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Patients with systemic lupus erythematosus (SLE), an autoimmune disease, have a higher risk of cardiovascular (CV) disease and death. In addition, up to 40%\u201350% of SLE patients develop lupus nephritis (LN) and chronic kidney disease, which is an additional CV risk factor. Thus, the individual contributions of LN and other SLE-specific factors to CV events are unclear.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In this study, we investigated the effect of LN on the development of CV changes using the female NZBxNZW F1 (NZB\/W) mouse model of lupus-like disease, with female NZW mice as controls. Standard serologic, morphologic, immunohistologic, and molecular analyses were performed. In a separate group of NZB\/W mice, systolic blood pressure (BP) was measured during the course of the disease using tail plethysmography.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Our data show marked CV changes in NZB\/W mice, i.e., increased heart weight, hypertrophy of the left ventricle (LV) and septum, and increased wall thickness of the intramyocardial arteries and the aorta, which correlated with the progression of renal damage, but not with the age of the mice. In addition, systolic BP was increased in NZB\/W mice only when kidney damage progressed and proteinuria was present. Pathway analysis based on gene expression data revealed a significant upregulation of the response to interferon beta in NZB\/W mice with moderate kidney injury compared with NZB mice. Furthermore, IFI202b and IL-6 mRNA expression is correlated with CV changes. Multiple linear regression analysis demonstrated serum urea as a surrogate marker of kidney function and IFI202b expression as an independent predictor for LV wall thickness. In addition, deposition of complement factors CFD and C3c in hearts from NZB\/W mice was seen, which correlated with the severity of kidney disease.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Thus, we postulate that the pathogenesis of CV disease in SLE is affected by renal impairment, i.e., LN, but it can also be partly influenced by lupus-specific cardiac expression of pro-inflammatory factors and complement deposition.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fcvm.2023.1182193","type":"journal-article","created":{"date-parts":[[2023,7,24]],"date-time":"2023-07-24T09:05:38Z","timestamp":1690189538000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":13,"title":["Cardiovascular changes in the NZB\/W F1 mouse model of lupus nephritis"],"prefix":"10.3389","volume":"10","author":[{"given":"Romy","family":"B\u00f6hme","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Daniel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fulvia","family":"Ferrazzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam","family":"Angeloni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arif B\u00fclent","family":"Ekici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas H.","family":"Winkler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl-Friedrich","family":"Hilgers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ute","family":"Wellmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reinhard E.","family":"Voll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerstin","family":"Amann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,7,24]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/s0065-2776(06)92001-x","article-title":"Systemic lupus erythematosus: multiple immunological phenotypes in a complex genetic disease","volume":"92","author":"Fairhurst","year":"2006","journal-title":"Adv Immunol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1080\/00325481.1995.11945982","article-title":"Systemic lupus erythematosus. Recognizing its various presentations","volume":"97","author":"Von Feldt","year":"1995","journal-title":"Postgrad Med"},{"key":"B3","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1080\/08916930400022616","article-title":"Anti-DNA antibodies: a diagnostic and prognostic tool for systemic lupus erythematosus?","volume":"38","author":"Riboldi","year":"2005","journal-title":"Autoimmunity"},{"key":"B4","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1191\/0961203306lu2305xx","article-title":"Epidemiology of systemic lupus erythematosus: a comparison of worldwide disease burden","volume":"15","author":"Danchenko","year":"2006","journal-title":"Lupus"},{"key":"B5","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1016\/S0889-857X(21)00891-7","article-title":"Systemic lupus erythematosus","volume":"16","author":"Hochberg","year":"1990","journal-title":"Rheum Dis Clin North Am"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1136\/ard.51.12.1292","article-title":"Epidemiology of systemic lupus erythematosus","volume":"51","author":"Hopkinson","year":"1992","journal-title":"Ann Rheum Dis"},{"key":"B7","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/s1074-7613(01)00201-1","article-title":"Delineating the genetic basis of systemic lupus erythematosus","volume":"15","author":"Wakeland","year":"2001","journal-title":"Immunity"},{"key":"B8","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1006\/jaut.2000.0409","article-title":"Epidemiology of the antiphospholipid antibody syndrome","volume":"15","author":"Petri","year":"2000","journal-title":"J Autoimmun"},{"key":"B9","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1177\/0961203315627202","article-title":"Overall and cause-specific mortality in systemic lupus erythematosus: an updated meta-analysis","volume":"25","author":"Lee","year":"2016","journal-title":"Lupus"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1136\/ard.61.12.1065","article-title":"Definition of risk factors for death, end stage renal disease, and thromboembolic events in a monocentric cohort of 338 patients with systemic lupus erythematosus","volume":"61","author":"Manger","year":"2002","journal-title":"Ann Rheum Dis"},{"key":"B11","doi-asserted-by":"publisher","first-page":"iv8","DOI":"10.1093\/rheumatology\/kel308","article-title":"Heart involvement in systemic lupus erythematosus, anti-phospholipid syndrome and neonatal lupus","volume":"45","author":"Tincani","year":"2006","journal-title":"Rheumatology (Oxford)"},{"key":"B12","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1093\/rheumatology\/keu412","article-title":"Birmingham SLE cohort: outcomes of a large inception cohort followed for up to 21 years","volume":"54","author":"Yee","year":"2015","journal-title":"Rheumatology (Oxford)"},{"key":"B13","doi-asserted-by":"publisher","first-page":"107466","DOI":"10.1016\/j.intimp.2021.107466","article-title":"Patients with systemic lupus erythematosus face a high risk of cardiovascular disease: a systematic review and meta-analysis","volume":"94","author":"Lu","year":"2021","journal-title":"Int Immunopharmacol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/s40620-020-00758-5","article-title":"Coronary artery disease in dialysis patients: evidence synthesis, controversies and proposed management strategies","volume":"34","author":"Burlacu","year":"2021","journal-title":"J Nephrol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1016\/s0952-7915(98)80094-0","article-title":"Susceptibility to lupus nephritis in the NZB\/W model system","volume":"10","author":"Morel","year":"1998","journal-title":"Curr Opin Immunol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1097\/00004872-199309000-00011","article-title":"The effect of enalapril on glomerular growth and glomerular lesions after subtotal nephrectomy in the rat: a stereological analysis","volume":"11","author":"Amann","year":"1993","journal-title":"J Hypertens"},{"key":"B17","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/0002-9343(83)90338-8","article-title":"Prognostic factors in lupus nephritis. Contribution of renal histologic data","volume":"75","author":"Austin","year":"1983","journal-title":"Am J Med"},{"key":"B18","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1038\/ki.1984.75","article-title":"Diffuse proliferative lupus nephritis: identification of specific pathologic features affecting renal outcome","volume":"25","author":"Austin","year":"1984","journal-title":"Kidney Int"},{"key":"B19","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1681\/asn.V10177","article-title":"Hypertrophy of intramyocardial arteriolar smooth muscle cells in experimental renal failure","volume":"10","author":"T\u00f6rnig","year":"1999","journal-title":"J Am Soc Nephrol"},{"key":"B20","year":""},{"key":"B21","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1093\/nar\/gkv007","article-title":"Limma powers differential expression analyses for RNA-sequencing and microarray studies","volume":"43","author":"Ritchie","year":"2015","journal-title":"Nucleic Acids Res"},{"key":"B22","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B23","doi-asserted-by":"publisher","first-page":"100141","DOI":"10.1016\/j.xinn.2021.100141","article-title":"Clusterprofiler 4.0: a universal enrichment tool for interpreting omics data","volume":"2","author":"Wu","year":"2021","journal-title":"Innovation (Camb)"},{"key":"B24","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/1471-2105-7-85","article-title":"Statistical analysis of real-time PCR data","volume":"7","author":"Yuan","year":"2006","journal-title":"BMC Bioinformatics"},{"key":"B25","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1111\/j.1525-139X.2008.00454.x","article-title":"Hypertrophy and fibrosis in the cardiomyopathy of uremia\u2013beyond coronary heart disease","volume":"21","author":"Gross","year":"2008","journal-title":"Semin Dial"},{"key":"B26","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1093\/ndt\/17.5.759","article-title":"Prolonged calcium transients and myocardial remodelling in early experimental uraemia","volume":"17","author":"McMahon","year":"2002","journal-title":"Nephrol Dial Transplant"},{"key":"B27","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/0895-7061(94)00248-a","article-title":"Changes of vascular architecture independent of blood pressure in experimental uremia","volume":"8","author":"Amann","year":"1995","journal-title":"Am J Hypertens"},{"key":"B28","first-page":"2043","article-title":"Blood-pressure-independent wall thickening of intramyocardial arterioles in experimental uraemia: evidence for a permissive action of PTH","volume":"10","author":"Amann","year":"1995","journal-title":"Nephrol Dial Transplant"},{"key":"B29","doi-asserted-by":"publisher","first-page":"257","DOI":"10.2174\/1874192401004010257","article-title":"Experimental models of renal disease and the cardiovascular system","volume":"4","author":"Grossman","year":"2010","journal-title":"Open Cardiovasc Med J"},{"key":"B30","doi-asserted-by":"publisher","first-page":"11795","DOI":"10.1007\/s11033-022-07985-y","article-title":"Cardiomyocyte-specific overexpression of syndecan-4 in mice results in activation of calcineurin-NFAT signalling and exacerbated cardiac hypertrophy","volume":"49","author":"Lunde","year":"2022","journal-title":"Mol Biol Rep"},{"key":"B31","doi-asserted-by":"publisher","first-page":"3165","DOI":"10.1007\/s00467-022-05481-w","article-title":"Cardiac biomarkers in pediatric CKD\u2014a prospective follow-up study","volume":"37","author":"Lindblad","year":"2022","journal-title":"Pediatr Nephrol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/metabo12050415","article-title":"Lipidomics revealed aberrant lipid metabolism caused by inflammation in cardiac tissue in the early stage of systemic lupus erythematosus in a murine model","volume":"12","author":"Zhang","year":"2022","journal-title":"Metabolites"},{"key":"B33","doi-asserted-by":"publisher","first-page":"dmm036947","DOI":"10.1242\/dmm.036947","article-title":"Cardiac phenotype in mouse models of systemic autoimmunity","volume":"12","author":"Sanghera","year":"2019","journal-title":"Dis Model Mech"},{"key":"B34","doi-asserted-by":"publisher","first-page":"F450","DOI":"10.1152\/ajprenal.00472.2007","article-title":"Partial nephrectomy as a model for uremic cardiomyopathy in the mouse","volume":"294","author":"Kennedy","year":"2008","journal-title":"Am J Physiol Renal Physiol"},{"key":"B35","first-page":"107","article-title":"Differences in the occurrence of hypertension among (NZB X NZW)F1, MRL-lpr, and BXSB mice with lupus nephritis","volume":"116","author":"Rudofsky","year":"1984","journal-title":"Am J Pathol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"R1258","DOI":"10.1152\/ajpregu.90864.2008","article-title":"The pathophysiology of hypertension in systemic lupus erythematosus","volume":"296","author":"Ryan","year":"2009","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1001\/archinte.1976.03630090033009","article-title":"Hypertension and renal disease in systemic lupus erythematosus","volume":"136","author":"Budman","year":"1976","journal-title":"Arch Intern Med"},{"key":"B38","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1681\/ASN.V102413","article-title":"Lupus nephritis","volume":"10","author":"Cameron","year":"1999","journal-title":"J Am Soc Nephrol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1097\/00002281-200309000-00001","article-title":"Update on vascular disease in systemic lupus erythematosus","volume":"15","author":"Kao","year":"2003","journal-title":"Curr Opin Rheumatol"},{"key":"B40","first-page":"323","article-title":"Regulation of acute phase gene expression by inflammatory mediators","volume":"4","author":"Fey","year":"1987","journal-title":"Mol Biol Med"},{"key":"B41","doi-asserted-by":"publisher","first-page":"9060","DOI":"10.1021\/bi953033d","article-title":"Regulation of human C-reactive protein gene expression by two synergistic IL-6 responsive elements","volume":"35","author":"Li","year":"1996","journal-title":"Biochemistry"},{"key":"B42","first-page":"199","article-title":"Regulation of the human C-reactive protein gene, a major marker of inflammation and cancer","volume":"7","author":"Toniatti","year":"1990","journal-title":"Mol Biol Med"},{"key":"B43","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1186\/ar770","article-title":"SLE\u2014complex cytokine effects in a complex autoimmune disease: tumor necrosis factor in systemic lupus erythematosus","volume":"5","author":"Aringer","year":"2003","journal-title":"Arthritis Res Ther"},{"key":"B44","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1177\/0961203310367658","article-title":"C3a, TNF-alpha and interleukin myocardial expression in a case of fatal sudden cardiac failure during clinic reactivation of systemic lupus erythematosus","volume":"19","author":"Pomara","year":"2010","journal-title":"Lupus"},{"key":"B45","doi-asserted-by":"publisher","first-page":"550","DOI":"10.3389\/fimmu.2015.00550","article-title":"Pathogenic inflammation and its therapeutic targeting in systemic lupus erythematosus","volume":"6","author":"Gottschalk","year":"2015","journal-title":"Front Immunol"},{"key":"B46","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1136\/ard.59.4.243","article-title":"Cytokines and systemic lupus erythematosus","volume":"59","author":"Dean","year":"2000","journal-title":"Ann Rheum Dis"},{"key":"B47","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/bf00197515","article-title":"The role of cytokines in the immunopathogenesis of lupus","volume":"16","author":"Handwerger","year":"1994","journal-title":"Springer Semin Immunopathol"},{"key":"B48","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1177\/153537020422900915","article-title":"Proinflammatory cytokine genes are constitutively overexpressed in the heart in experimental systemic lupus erythematosus: a brief communication","volume":"229","author":"Tomita","year":"2004","journal-title":"Exp Biol Med (Maywood)"},{"key":"B49","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/s1568-9972(02)00100-3","article-title":"Accelerated atherogenesis in autoimmune rheumatic diseases","volume":"1","author":"Bacon","year":"2002","journal-title":"Autoimmun Rev"},{"key":"B50","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1006\/cyto.2000.0705","article-title":"Tumour necrosis factor-alpha expression in idiopathic dilated cardiomyopathy: correlation to myocardial inflammatory activity","volume":"12","author":"Sigusch","year":"2000","journal-title":"Cytokine"},{"key":"B51","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1161\/01.cir.97.14.1340","article-title":"Tumor necrosis factor-alpha and cardiomyopathy","volume":"97","author":"Bristow","year":"1998","journal-title":"Circulation"},{"key":"B52","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1016\/s0024-3205(01)01509-0","article-title":"Interleukin-18 reduces expression of cardiac tumor necrosis factor-alpha and atrial natriuretic peptide in a murine model of viral myocarditis","volume":"70","author":"Yoshida","year":"2002","journal-title":"Life Sci"},{"key":"B53","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/s0002-9343(02)01223-8","article-title":"Myocarditis in systemic lupus erythematosus","volume":"113","author":"Wijetunga","year":"2002","journal-title":"Am J Med"},{"key":"B54","doi-asserted-by":"publisher","first-page":"6549","DOI":"10.3390\/ijms24076549","article-title":"Cadherin-11-interleukin-6 signaling between cardiac fibroblast and cardiomyocyte promotes ventricular remodeling in a mouse pressure overload-induced heart failure model","volume":"24","author":"Fang","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B55","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/s0002-9440(10)64201-0","article-title":"Complement and dilated cardiomyopathy: a role of sublytic terminal complement complex-induced tumor necrosis factor-alpha synthesis in cardiac myocytes","volume":"161","author":"Zwaka","year":"2002","journal-title":"Am J Pathol"},{"key":"B56","doi-asserted-by":"publisher","first-page":"483","DOI":"10.4049\/jimmunol.154.2.483","article-title":"IL-15 has stimulatory activity for the induction of B cell proliferation and differentiation","volume":"154","author":"Armitage","year":"1995","journal-title":"J Immunol"},{"key":"B57","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1084\/jem.180.4.1395","article-title":"Interleukin (IL) 15 is a novel cytokine that activates human natural killer cells via components of the IL-2 receptor","volume":"180","author":"Carson","year":"1994","journal-title":"J Exp Med"},{"key":"B58","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1126\/science.8178155","article-title":"Cloning of a T cell growth factor that interacts with the beta chain of the interleukin-2 receptor","volume":"264","author":"Grabstein","year":"1994","journal-title":"Science"},{"key":"B59","doi-asserted-by":"publisher","first-page":"6644631","DOI":"10.1155\/2021\/6644631","article-title":"Myokines and heart failure: challenging role in adverse cardiac remodeling, myopathy, and clinical outcomes","volume":"2021","author":"Berezin","year":"2021","journal-title":"Dis Markers"},{"key":"B60","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1093\/rheumatology\/40.8.876","article-title":"Serum interleukin-15 is elevated in systemic lupus erythematosus","volume":"40","author":"Aringer","year":"2001","journal-title":"Rheumatology (Oxford)"},{"key":"B61","first-page":"364","article-title":"Proinflammatory interferon-gamma\u2013inducing monokines (interleukin-12, interleukin-18, interleukin-15)\u2013serum profile in patients with systemic lupus erythematosus","volume":"13","author":"Robak","year":"2002","journal-title":"Eur Cytokine Netw"}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2023.1182193\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,24]],"date-time":"2023-07-24T09:05:53Z","timestamp":1690189553000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2023.1182193\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,24]]},"references-count":61,"alternative-id":["10.3389\/fcvm.2023.1182193"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2023.1182193","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,24]]},"article-number":"1182193"}}